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In search of hormones and drugs which might elevate 
the intracellular level of cyclic GMP in pig epidermis, we 
have tested the effects of carbachol, concanavalin A, 
prostaglandin F 2", insulin, epinephrine, Vitamin A acid 
and histamine. Only histamine was found to cause con-
sistent activation of the cyclic GMP system. Epidermal 
slices incubated in Hank's balanced salt solution with 
histamine exhibited 2- to 4-fold increases in intracellular 
cyclic GMP concentrations. Histamine's effect on cyclic 
GMP was not due to contamination by the lOOO-fold 
higher level of cyclic AMP. The time course after hista-
mine addition showed maximal response for cyclic GMP 
at 1 min and for cyclic AMP at 5 min. Leakage of cyclic 
GMP into the media was much more marked than that of 
cyclic AMP. Maximal histamine activation of the cyclic 
GMP system required a 1 mM concentration, whereas 
that for the cyclic AMP system required only a 100 P.M 
final concentration. 3-Isobutyl, 1-methylxanthine (IBMX) 
highly potentiated the effect of histamine on both cyclic 
nucleotides, but the synergistic effect was more marked 
in relation to cyclic GMP accumulation. Histamine acti-
vation of the cyclic AMP system was specifically in-
hibited by an (H2 ) inhibitor. Although both (HI) and (H2 ) 
inhibitors significantly reduced histamine activation of 
the cyclic GMP system, the inhibition by the (HI) inhibi-
tor was predominant. These results indicate that the pig 
epidermis has a weak but distinct histamine-guanylate 
cyclase system. 
Recent reports indicate that cyclic GMP in mammalial tissue 
may play an important biological role in cell growth, and 
malignant transformation [1-8]. In many cases an increase in 
cyclic GMP is implicated in rapid growth [1-6], while in others 
a low cyclic GMP level is implicated in cell proliferation 
[9,10]. The effects of cyclic GMP are so variable and diverse 
depending on the kinds and conditions of organs involved that 
any generalization of their role in growth and differentiation is 
extremely difficult (for a recent review; see reference 7). At 
present the only way to study its role appears to be to select a 
specific organ as the subject and to defme the experimental 
conditions rigidly. 
Information on the cyclic GMP system in epidermis has been 
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extremely limited. One study reported that in psoriasis the level 
of cyclic GMP was increased [8]; but another study showed 
that the addition of cyclic GMP or dituyryl cyclic GMP did not 
significantly influence the rate of the epidermal mitosis in 
culture [11]. 
We now report the effects on skin of hormones and chemicals 
which have been reported to stimulate the guanylate cyclase in 
other tissues. Only histamine has modest stimulatory effect on 
the epidermal guanylate cyclase system of pig skin. 
MATERIALS AND METHODS 
Thin slices of epidermis were obtained from domestic pigs weighing 
6-8 kg by a Castroviejo keratome set at 0.3 mm depth. The epidermal 
slices were cut into 5 x 5 mm squares and kept at 4°C in Hank's 
balanced salt solution. After preincubation of the skin squares at 37°C 
for 15-20 min to stabilize both cyclic-AMP and cyclic-GMP levels in 
the tissue, 4 squares each were incubated with test hormones or drugs 
for short periods as specified below. Cyclic nucleotides were extracted 
and measured as described in the preceding paper [12). However the 
succinylation step before the radioimmunoassay was replaced by ace-
tylation, which yielded consistent results for measurements of both 
cyclic AMP and cyclic GMP [13,14)' Protein was measured by the 
method of Lowry et al [15] after dissolving the perchloric acid-precip-
itate in 1 N NaOH at room temperature for 1-2 hr. Sources for 
radioactive and nonradioactive drugs and chemicals are the same as 
described in the preceding paper [12). 
Epinephrine was the product of Parke Davis (Detroit, Mich.), and 
metiamide was a kind gift from Dr. Brimblecombe, Smith, Kline and 
French Lab., U.K. Chemicals and drugs were prepared fresh and the 
pH of the solution was adjusted to 7 before each experiment. 
RESULTS 
The intracellular concentrations of cyclic GMP and cyclic 
AMP rose in response to histamine (Fig 1). The intracellular 
cyclic GMP level reached maximal accumulation at 1 min and 
remained relatively high for 5 min. In contrast, the level of 
cyclic AMP continuously increased and reached a peak in 5 
min . Histamine caused 2- to 4-fold accumulation of cyclic GMP 
as compared with a 20-fold accumulation of cyclic AMP. Cyclic 
GMP accumulated in the media, while cyclic AMP did not. 
Cyclic GMP appears to "leak" from epidermal cells more easily 
than cyclic AMP. Cyclic GMP accumulation in the skin was 
dose dependent and the maximal effect was observed at 1 mM 
(Fig 2), whereas in previous studies cyclic AMP accumulation 
was nearly maximal at 100 J.LM (c.f. reference 16). 
Hi~tamine and a potent cyclic nucleotide-phosphodiesterase 
inhibitor, 3-isobutyl, I-methylxanthine (IBMX), were added 
singly or in combination (Fig 3). IBMX by itself greatly en-
hanced the cyclic GMP accumulation, but elevated only slightly 
the cyclic AMP level. Histamine alone caused much higher 
stimulation of cyclic AMP accumulation. Simultaneous addi-
tion of both IBMX and histamine was synergistic for both 
cyclic GMP and cyclic AMP, but the degree of synergism was 
much higher for cyclic GMP than cyclic AMP. 
Diphenhydramine, a histamine (H,) antagonist, inhibited 
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FIG 1. Time course of the effect of histamine. After preincubation 
for 15 min, the epidermal squares were incubated for the indicated 
periods in Hank's balanced salt solution containing 1 mM histamine. 
No phosphodiesterase inhibitor was added to the medium. Each value 
is an average of 2 determinations unless otherwise specified. (0 )---
intracellular levels of cyclic nucleotides in the control epidermis (no 
histamine added) and (e)---those in the media with histamine. The 
cyclic nucleotide values in the media, with histamine (.) and without 
histamine, i.e. "control; (0), were expressed on a per mg protein basis 
of the epidermal squares in the particular incubation. 
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FIG 2. The effect of histamine concentration. The epidermis were 
incubated with various concentrations of histamine for 1 min. Prein-
cubation was done for 15 min. No phosphodiesterase inhibitor was 
added to the medium. (An average of 2 experiments, each assayed in 
duplicate.) 
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histamine stimulation of the cyclic GMP system, but did not 
inhibit that of the cyclic AMP system (Fig 4). The effect of 
another histamine (Hd inhibitor, pyrilamine was also tested 
with essentially the same results. Pyrilamine at a final concen-
tration of 100 J.!M and 1 mM inhibited 90% of the cyclic GMP 
increase due .to histamine (1 mM) activation. No effect of 
pyrilamine on histamine stimulation of the cyclic AMP system 
was observed. Metiamide, a histamine (H2) inhibitor, at 1 mM 
final concentration which was equal to the histamine concen-
tration, inhibited 95% of the cyclic AMP activation, but dem-
onstrated only 60% inhibition of the cyclic GMP activation (Fig 
5) . At 100 J.!M (1/ 10 of the histamine concentration) , it inhibited 
nearly 70% of the cyclic AMP accumulation and only 40% of 
the cyclic GMP accumulation. 
To ensure that the cyclic GMP fraction we have been assay-
ing does not include spill-over from the cyclic AMP fraction, 
we examined the effects of epinephrine on the epidermal aden-
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FIG 3. Histamine with or without a phosphodiesterase inhibitor 
(lBMX) . After preincubation, the epidermal squares were incubated 
for 1 min in Hank's balanced salt solution, containing lOO IlM IBMX 
(0), 100 IlM histamine (e) or 100 IlM each of both drugs (A) . The control 
medium (0 ) contained no drugs. (An average of 2 experiments, each 
assayed in duplicate.) 
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FIG 4. Effect of histamine (H,) inhibitor, diphenhydramine. After 
preincubation for 15 min the epidermal squares were incubated for 1 
min in Hank's balanced salt solution containing 1 mM histamine and 0, 
0.1 and 1.0 mM diphenhydramine (e) . Control values, without histamine 
(0 ) at 0 and another control, diphenhydramine alone (0 ) at 1 mM are 
essentially the same. (An average of 2 experiments, each assayed in 
duplicate.) 
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ylate and guanylate cyclase systems (Fig 6). Epinephrine clearly 
stimulated t he adenylate cyclase system, Nhereas there was no 
effect on the guanylate cyclase system (note at 5 min of the 
incubation, t he intracellular cyclic AMP level is 1,500-fold 
higher than the cyclic G MP level). Since this cyclic AMP level 
did not result in cyclic GMP accumulation in this experiment, 
we conclude that there is no "spill-over." 
The Table summarizes the effects of various hormones and 
drugs which have been reported to stimulate t he guanylate 
cyclase system in mammalian t issues. None of them convinc-
ingly elevated cyclic GMP in epidermis. The baseline cyclic 
GMP content from skin to skin varies considerably, but within 
each experiment where control and experimental material are 
from the same skin the results are reproducible. 
DISCUSSION 
We have aimed at 2 major questions: (1) what are the 
hormones or chemicals which can stimulate the epidermal 
cyclic GMP system?; and (2) does cyclic GMP control epidermal 
cell mitosis and proliferation? 
To answer the fIrst question we have tested the effects of 
carbachol, concanavalin A, prostaglandin F~", insulin, and vi-
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FIG 5. Effect of histam ine (H1 ) inhibito r, metiamide. Experimental 
conditions were the same as described in Fig 4 except that the (H,) 
inhibitor was replaced by the (H1 ) inhibito r at 0, 0.1 and 1.0 mM (e). 
One of 3 similar experiments is shown. Each point is the average of 2 
determinations. 
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tamin A acid, but none of them convincingly stimulated the 
epidermal cyclic GMP system. The only drug which stimulated 
the system was histamine. Since histamine also markedly stim-
ulates the cyclic AMP system [16], we have tried to. study its 
effects on both the cyclic GMP and cyclic AMP systems simul-(I Cyclic GMP 
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F IG 6. Differential effects of epinephrine on cyclic GMP and cyclic 
AMP accumu lation in pig epidermis. The epiderma l squares were 
incubated in Hank's bala nced salt solution with 50 /LM epinephrine 
(e). The contro l medium (0 ) contained no epinephrine. No phospho-
diesterase inhibitor was added to either medium. Cyclic nucleotide 
levels in media were measured a lso (. = epinephrine, 0 = control). 
One of 3 similar experiments is shown. Each point is t he average of 2 
determinations on 4 combined pieces of skin. 
Effects of hormones and chemicals on the accumulation of cyclic GMP (f moll mg protein ± ~E) in the epidermal slices 
Hormones Final & 
concl. 
chemicals 
PGF~" 40/LM 
Carbachol 1 nlM(I 
Ins ulin 0.4 /Lg/ml 
Vito A acid 600 /LM 
0 
18.3 
± 2.0 
(n = 12) 
12.5 
± 1.9 
(n = 4) 
19.1 
± 1.6 
(n = 8) 
30.3 32.7 
± 1.4 
(n = 4) 
Incubation time (min) 
18.7 
± 3.0 
(n = 4) 
13.0 
± 1.9 
(n = 4) 
20.3 
± 2.7 
(n = 4) 
22.6 
5 
19.6 
± 2.0 
(n = 7) 
10.0 
(n = 2) 
25.2 
(n = 2) 
23.3 
(Ave. = 27.6 ± 3. 1, n = 2 ea.) 
10 
37.3 
Con. A 10 jtg/mllo 18.6 20.8 24 .1 23.1 14.6 
± 1.9 
(n = 6) 
(Ave. = 20.3 ± 1.6, n = 2 ea.) 
" An additional experiment with t he concentration range of 1 /LM -5 mM showed no effect at 1 & 5 min of incubation. 
b Repeated experiment wit h 0.2, 2, 20, 200 /Lg/ ml of con A showed also no effect. 
20 
22.0 
18.7 
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taneously and comparat ively. The degree of histamine activa-
t ion of the cyclic GMP system is not extraordinary, but the 
evidence supporting its posit ive effect appears to be sufficient. 
Namely, the t ime course for cyclic GMP accumulation, and the 
effects of histamine concent ration on the cyclic G M P and cyclic 
AMP systems are diffe rent. Furthermore the histamine-aden-
ylate cyclase system has strictly (H2 ) type receptors, whereas 
the histamine-guanylate cyclase system has both (H,) and (H2) 
bu t predomina ntly (H,) type receptors (Fig 4 and 5). 
The occurrence of the histamine-guanylate cyclase system 
has been described in only 2 organs thus far. One is in guinea 
pig bra in [17) or bra in tumor cells [18] and t he other in smooth 
muscle of human umbilical ar tery [19). Epidermis is now the 
thi.rd organ reported to have such a system. In the brain system, 
histamine appa rently functions as one of the neurotransmitters, 
and in the artery histamine increase the level of cyclic GMP 
which appears to playa role in smooth muscle contraction . In 
epidermis however, no clear cut function of histamine and cyclic 
GMP has yet been shown. 
In the epidermal outgrowth culture system [11] histamine 
blocked mitosis at 10- 1; M, which can be within physiological 
range. T hat particular histamine action appeared to be me-
diated by cyclic AMP, since t he addit ion of dibutyryl cyclic 
AMP but not dibutyryl cyclic GM P also caused mitot ic inhi-
bit ion [11). In vivo data on t he cyclic GM P level in skin consists 
of a repor t that cyclic GMP in the lesional epidermis of pso-
ria t ics is high as compared with that in the involved epidermis 
[8). T he steady state level of cyclic AMP in the involved and 
uninvolved epidermis a re about eq ual [20-22). At present , the 
biological role of the histamine-guanylate cyclase system in the 
epidermis remains unanswered. 
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